hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06264414, orgStudyIdInfo id: DTT106-III-0123, briefTitle: Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia, acronym: AUSTRÁLIA, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2025-02, primaryCompletionDateStruct date: 2026-06, completionDateStruct date: 2027-07, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: EMS, class: INDUSTRY, descriptionModule briefSummary: The purpose of this study is to assess the safety and efficacy of the DTT106 in the treatment of erectile dysfunction associated with benign prostatic hyperplasia, conditionsModule conditions: Prostatic Hyperplasia, Benign, conditions: Erectile Dysfunction, designModule studyType: INTERVENTIONAL, phases: PHASE3, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 262, type: ESTIMATED, armsInterventionsModule interventions name: DTT106, interventions name: Dutasteride-Tamsulosin, outcomesModule primaryOutcomes measure: Change in the Erectile Function domain score of the International Index of Erectile Function (IIEF-EF) at the end of treatment, from baseline., secondaryOutcomes measure: Change in maximum urinary flow rate (Qmax), secondaryOutcomes measure: Decrease in post-void residual volume (PVR), secondaryOutcomes measure: Improvement in urinary symptoms., secondaryOutcomes measure: Improvement in urinary emptying symptoms, secondaryOutcomes measure: Improvement in urinary storage symptoms., secondaryOutcomes measure: Improvement in the participant's quality of life in relation to their urinary condition, secondaryOutcomes measure: Improvement in the participant's sexual function, secondaryOutcomes measure: Improvement in the participant's orgasmic function., secondaryOutcomes measure: Effectiveness of the treatment in improving the participant's sexual desire, secondaryOutcomes measure: Effectiveness in improving the participant's satisfaction with sexual relations, secondaryOutcomes measure: Overall satisfaction of the participant regarding their sex life., eligibilityModule sex: MALE, minimumAge: 40 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: EMS, city: Hortolândia, state: São Paulo, country: Brazil, geoPoint lat: -22.85833, lon: -47.22, hasResults: False
protocolSection identificationModule nctId: NCT06264401, orgStudyIdInfo id: menopausal with osteoporsis, briefTitle: Treatment Exercises With Core Stability and Dynamic Resistance Exercise for Postmenopausal Women With Osteoporosis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-22, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-02-21, sponsorCollaboratorsModule leadSponsor name: Cairo University, class: OTHER, descriptionModule briefSummary: osteoporosis is a common disease that affect most of postmenopausal women. various treatment procedures are used to avoid future complain among postmenopausal population., conditionsModule conditions: Postmenopausal Osteoporosis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: intervention: medication the experimental and control groups received (Alendronate) 70 mg 1 tab every week for 4 months.treatment exercises the experimental group performed core stability and dynamic resistance exercises, a 45-min lumbar-pelvic/core strength and stability exercise program which include 5 min warming up and 5 min cooling down at the end of the session each exercise was executed for three sets of 15 seconds, which gradually upgraded to three sets of 45-second at the fourth month and 10 sec rest between each set and dynamic resistance exercise performed by each woman for 2 sets for 8-12 repetitions gradually along the study of 90 sec rest between each set for a duration of 60 min including 10 min warming up and 10 min cooling down in form of stretching., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: Alendronate, interventions name: treatment exercises, outcomesModule primaryOutcomes measure: Dual-energy x-ray absorptiometry, primaryOutcomes measure: Oswestry Disability Index, eligibilityModule sex: FEMALE, minimumAge: 50 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule locations facility: faculty of physical therapy, Cairo university, city: Giza, zip: 12662, country: Egypt, contacts name: Nermeen Abd El Aziem, phd, role: CONTACT, phone: 01025016087, email: nermeenshaaban93o@yahoo.com, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06264388, orgStudyIdInfo id: 20231234, secondaryIdInfos id: R21CA282543, type: NIH, link: https://reporter.nih.gov/quickSearch/R21CA282543, briefTitle: DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-05-01, primaryCompletionDateStruct date: 2034-05-01, completionDateStruct date: 2034-05-01, studyFirstPostDateStruct date: 2024-02-20, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: Ashish Shah, class: OTHER, collaborators name: Denovo Biopharma LLC, collaborators name: National Cancer Institute (NCI), descriptionModule briefSummary: The purpose of this study is to determine if the investigational products, DB107-RRV and DB107-FC, as a combination treatment will shrink high-grade glioma (HGG) in patients with recurrent/progressive, resectable or unresectable disease and increase the time that disease is controlled., conditionsModule conditions: High Grade Glioma, conditions: Anaplastic Astrocytoma, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 33, type: ESTIMATED, armsInterventionsModule interventions name: DB107-RRV, interventions name: DB107-FC, outcomesModule primaryOutcomes measure: Progression Free Survival, primaryOutcomes measure: Overall Survival, secondaryOutcomes measure: Assessment of Tumor Status Measured by Response Assessment in Neuro-oncology (RANO) Criteria, secondaryOutcomes measure: Number of Treatment Related Toxicities, secondaryOutcomes measure: Durable Response Rate (DRR), secondaryOutcomes measure: Durable Clinical Benefit Rate (DCBR), secondaryOutcomes measure: Duration of Durable Response Rate, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Miami Hospital, status: RECRUITING, city: Miami, state: Florida, zip: 33136, country: United States, contacts name: Leonela Wright, MSN, RN, role: CONTACT, phone: 305-243-0864, email: lxw612@med.miami.edu, contacts name: Ashish Shah, MD, role: CONTACT, phone: 305-243-6946, email: ashah@med.miami.edu, contacts name: Ashish Shah, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 25.77427, lon: -80.19366, hasResults: False
protocolSection identificationModule nctId: NCT06264349, orgStudyIdInfo id: 05102023, briefTitle: Women and Maternity: Development of a Nutritional Education Project, acronym: MATER, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2025-05-15, completionDateStruct date: 2025-11-30, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: University of Pavia, class: OTHER, descriptionModule briefSummary: The "first 1000 days of life", from conception to 2 years of life, are crucial for promoting the health of both mother and baby. During this period, a woman's diet and lifestyle play a significant role in determining the future health of the child. The perinatal period is an ideal time for regular contact with healthcare providers who can institute an intervention to encourage pregnant women to make nutritional changes to improve their health and that of their babies.Therefore, an educational program on an appropriate lifestyle during the "first 1000 days" can represent a crucial primary prevention strategy in reducing the risk of developing obesity and non-communicable diseases (NCDs) during childhood and later adulthood., conditionsModule conditions: Pregnancy, conditions: Lactation, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Quasi-experimental - controlled, non-randomized pilot study, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Lifestyle Educational Intervention, outcomesModule primaryOutcomes measure: Gestational weight gain management, secondaryOutcomes measure: Nutritional aspects evaluation during pregnancy and lactation, secondaryOutcomes measure: Physical activity evaluation during pregnancy and lactation, secondaryOutcomes measure: Smoking habits during pregnancy and lactation, secondaryOutcomes measure: Maternal attitude towards infant feeding., eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06264336, orgStudyIdInfo id: UIC AHS Pilot 2024, briefTitle: Effects of High-intensity Gait Training on Fatigue, Gait, and Neuroplasticity in People With Multiple Sclerosis, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-28, sponsorCollaboratorsModule leadSponsor name: University of Illinois at Chicago, class: OTHER, descriptionModule briefSummary: Nearly 1 million individuals in the United States have multiple sclerosis, which causes fatigue and problems with walking. Fatigue and walking problems are poorly treated, but exercise training, particularly high-intensity walking exercise, may help. This provide insight into whether high-intensity walking exercise can improve fatigue and walking problems in people with multiple sclerosis, which could improve quality of life and reduce economic burden., conditionsModule conditions: Multiple Sclerosis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: treadmill training, outcomesModule primaryOutcomes measure: Symptomatic fatigue, primaryOutcomes measure: Walking speed, primaryOutcomes measure: Corticomotor excitability, secondaryOutcomes measure: Fatigue impact, secondaryOutcomes measure: Walking endurance, secondaryOutcomes measure: Aerobic capacity, secondaryOutcomes measure: Visual processing speed, secondaryOutcomes measure: Verbal learning and memory, otherOutcomes measure: Spatial walking symmetry, otherOutcomes measure: Temporal walking symmetry, otherOutcomes measure: Community ambulation, otherOutcomes measure: Interhemispheric inhibition, eligibilityModule sex: ALL, minimumAge: 21 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Illinois Chicago, status: RECRUITING, city: Chicago, state: Illinois, zip: 60612, country: United States, contacts name: Brice T Cleland, PhD, role: CONTACT, phone: 312-996-9056, email: bcleland@uic.edu, geoPoint lat: 41.85003, lon: -87.65005, hasResults: False
protocolSection identificationModule nctId: NCT06264323, orgStudyIdInfo id: UI-5487, briefTitle: Incidence of Acute Injuries in Boxing, statusModule overallStatus: COMPLETED, startDateStruct date: 2017-09-01, primaryCompletionDateStruct date: 2018-05-30, completionDateStruct date: 2018-11-30, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: University of Iceland, class: OTHER, descriptionModule briefSummary: A prospective cohort study with 9 months follow up was carried out in 2017-2018. Boxers of both sexes 18 years and older from all 7 boxing clubs in Iceland were invited to participate in the study. Participants filled out a questionnaire on previous injuries during boxing training and competition and were evaluated on the Sport Concussion Assessment Tool 3rd edition (SCAT3). Exposure at training and competition was measured and any injuries sustained during the study period were recorded via text messages and phone calls every 2 weeks., conditionsModule conditions: Injuries, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 74, type: ACTUAL, outcomesModule primaryOutcomes measure: Questionnaire, primaryOutcomes measure: Sport Concussion Assessment Tool 3rd Edition (SCAT3), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Iceland, city: Reykjavík, zip: 102, country: Iceland, geoPoint lat: 64.13548, lon: -21.89541, hasResults: False
protocolSection identificationModule nctId: NCT06264297, orgStudyIdInfo id: 01-22-270-111, briefTitle: High-Voltage Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion for the Treatment of Chronic Lumbar Radicular and Neuropathic Pain; A Prospective, Doble-blinded and Randomized Controlled Trial, acronym: Radiofrequency, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-02-20, primaryCompletionDateStruct date: 2027-01, completionDateStruct date: 2027-12, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: Consorci Sanitari de Terrassa, class: OTHER, descriptionModule briefSummary: The management of chronic lumbar radicular and neuropathic pain is complex and the treatment success rates are low. Pulsed radiofrequency (PRF) has been described in these cases. In order to determine whether high-voltage PRF show better results than PRF a prospective, doble-blinded and randomized study is conducted in patients with chronic lumbar radicular and neuropathic pain., conditionsModule conditions: Pulsed Radiofrequency, conditions: Lumbar Radiculopathy, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, enrollmentInfo count: 98, type: ESTIMATED, armsInterventionsModule interventions name: Radiofrequency, outcomesModule primaryOutcomes measure: OSWESTRY LOW BACK DISABILITY QUESTIONNAIRE, secondaryOutcomes measure: DN4 - QUESTIONNAIRE, secondaryOutcomes measure: Visual Numeric Scale, secondaryOutcomes measure: Categorical scale, secondaryOutcomes measure: patient global impression of improvement (pgi-i) score, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Consorci Sanitari de Terrassa, status: RECRUITING, city: Terrassa, state: Barcelona, zip: 08227, country: Spain, contacts name: Maria Martinez Garcia, role: CONTACT, phone: +34650528215, email: mariamartinezgarcia@gmail.com, contacts role: CONTACT, email: mariamartinezgarcia@gmail.com, contacts name: maria Martinez Garcia, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 41.56667, lon: 2.01667, hasResults: False
protocolSection identificationModule nctId: NCT06264284, orgStudyIdInfo id: 2023PI163, briefTitle: Emergency (Red Code) Cesarean Section : Maternal and Fetal Prognosis Depending on Anesthetic Modalities in a Level 3 Maternity Ward, statusModule overallStatus: COMPLETED, startDateStruct date: 2018-07-19, primaryCompletionDateStruct date: 2023-07-19, completionDateStruct date: 2023-07-19, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: Central Hospital, Nancy, France, class: OTHER, descriptionModule briefSummary: We try to evaluate whether the type of anesthesia used influences the occurrence of perioperative maternal complications as well as neonatal outcome on emergency (Red Code) Cesarean Section.This study occurred in a Level 3 Maternity Ward., conditionsModule conditions: Anesthesia Complication, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: RETROSPECTIVE, enrollmentInfo count: 150, type: ACTUAL, armsInterventionsModule interventions name: epidural anesthesia, interventions name: general anesthesia, outcomesModule primaryOutcomes measure: To evaluate whether the type of anesthesia used influences the occurrence of perioperative maternal complications as well as neonatal outcome, eligibilityModule sex: FEMALE, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Stanowski, city: Nancy, zip: 54000, country: France, geoPoint lat: 48.68439, lon: 6.18496, hasResults: False
protocolSection identificationModule nctId: NCT06264271, orgStudyIdInfo id: GIP-22-NL-06-203, briefTitle: The Effect of Nutrition Education on Glycemic Control in Patients With Type 1 Diabetes, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-02-01, primaryCompletionDateStruct date: 2023-12-31, completionDateStruct date: 2024-02-01, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: Charles University, Czech Republic, class: OTHER, collaborators name: General University Hospital, Prague, descriptionModule briefSummary: The study aims to elucidate whether patients with T1D initiating sensor monitoring experience greater improvement in glycemic control (HbA1c) when provided with structured nutrition education compared to those initiating sensor monitoring without such education., conditionsModule conditions: Diabetes Mellitus, Type 1, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: RETROSPECTIVE, enrollmentInfo count: 329, type: ACTUAL, armsInterventionsModule interventions name: structured nutrition intervention, outcomesModule primaryOutcomes measure: difference in HbA1c, secondaryOutcomes measure: differences in time in range, secondaryOutcomes measure: differences in time below range, secondaryOutcomes measure: differences in time above range, secondaryOutcomes measure: differences in coefficient of variation, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Charles University, city: Prague, zip: 12808, country: Czechia, geoPoint lat: 50.08804, lon: 14.42076, hasResults: False
protocolSection identificationModule nctId: NCT06264232, orgStudyIdInfo id: AT ELANA 841P-BER-302-19, briefTitle: [Trial of device that is not approved or cleared by the U.S. FDA], statusModule overallStatus: WITHHELD, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-20, sponsorCollaboratorsModule leadSponsor name: [Redacted], hasResults: False
protocolSection identificationModule nctId: NCT06264219, orgStudyIdInfo id: H-24002284, briefTitle: Restoration of the Gut Microbiome After Cesarean Section, acronym: RestoreGut, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2025-11-30, completionDateStruct date: 2026-11-30, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: Professor Klaus Bønnelykke, class: OTHER, descriptionModule briefSummary: This study aims to develop a therapy for restoring the gut microbiome in infants born via CS. We will conduct a randomized, placebo-controlled feasibility trial to assess the ability of microbiome restoration by FMT and FVT in infants born by cesarean section., conditionsModule conditions: Microbial Colonization, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Microbiome restoration - FMT, interventions name: Microbiome restoration - FVT, interventions name: Placebo, interventions name: Vaginal birth, untreated control, outcomesModule primaryOutcomes measure: Microbial development trajectory, secondaryOutcomes measure: Microbial development trajectory, eligibilityModule sex: FEMALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Copsac, DBAC, city: Gentofte, state: Copenhagen, zip: 2820, country: Denmark, geoPoint lat: 55.74903, lon: 12.54601, locations facility: Rigshospitalet, city: Copenhagen, zip: 2100, country: Denmark, contacts name: Hanne Hegaard, Professor, role: CONTACT, phone: +45 27583632, email: Hanne.Kristine.Hegaard@regionh.dk, geoPoint lat: 55.67594, lon: 12.56553, hasResults: False
protocolSection identificationModule nctId: NCT06264206, orgStudyIdInfo id: CALLA_IVF_KIR, briefTitle: Effect of Immunomodulatory Treatment on IVF (in Vitro Fertilization) Outcomes in Patients With KIR AA Genotype, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-01-01, primaryCompletionDateStruct date: 2022-12-31, completionDateStruct date: 2023-12-31, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: Calla IVF Center, class: OTHER, descriptionModule briefSummary: The aim of the study is to investigate the immune cause of recurrent implantation failure (RIF) and the role of immunomodulatory treatment in IVF (in vitro fertilization) patients that have a KIR AA genotype. We compared pregnancy rates in Group KIR AA without immunomodulatory treatment, and pregnancy rates in Group KIR AA with immunomodulatory treatment., conditionsModule conditions: Immunomodulatory Drugs, conditions: Killer-cell Immunoglobulin-like Receptors (KIRs), conditions: KIR Alleles (KIR AA), designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 65, type: ACTUAL, armsInterventionsModule interventions name: Killer-cell immunoglobulin-like receptors (KIRs) testing, outcomesModule primaryOutcomes measure: the incidence of immune cause of recurrent implantation failure, primaryOutcomes measure: the efficiency of immnomodulatory treatment on pregnancy rate in patients with KIR AA, secondaryOutcomes measure: comparation between the pregnancy rates in KIR AA group and KIR Bx group, eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 49 Years, stdAges: ADULT, contactsLocationsModule locations facility: Calla Ivf Center, city: Oradea, state: Bihior, zip: 410103, country: Romania, geoPoint lat: 47.0458, lon: 21.91833, hasResults: False